Join an innovative global community focused on improving patient care, shaping effective policy, and ensuring the future of our field.
May 31, 2022
Thank you to all the attendees, speakers, and sponsors that joined us for ENDO 2022 both in-person and online. We were thrilled to welcome so many familiar faces, and many new ones, for our program in Atlanta and online. We look forward to seeing you again at ENDO 2023 June 15 - 18, 2022, in Chicago, IL!
June 20, 2022
Join us on September 8-10 to discover the latest developments in endocrinology diagnosis and treatments. This year, we are excited to announce our first CEU hybrid experience! For the first time since 2019, we will return to the in-person meeting at the Intercontinental Hotel in Miami, FL. Additionally, our entire program will also be available online. Register by July 28 to secure the lowest rates. Sign up today!
June 11, 2022
We are pleased to announce the release of our latest clinical practice guideline: Management of Hyperglycemia in Hospitalized Adult Patients in Non-Critical Care Settings! This new guideline reflects evolving clinical science and provides evidence-based recommendations for clinical care and practice managing hyperglycemia in the inpatient setting.
June 22, 2022
We are pleased to introduce the 2022 Endocrine Case Management: Meet the Professor E-Book! This comprehensive educational resource is designed to provide endocrinologists with a high-quality, concise review of common and rare endocrine disorders. Our E-Book will give you access to case-based vignettes and rationales to learn the nuances of patient care from over 35 experts in all areas of endocrinology, diabetes, and metabolism.
June 23, 2022
The Endocrine Society endorses the INSULIN Act and urges Congress to pass this legislation as soon as possible.
Need more info?
Learn more about the advantages of membership
June 23, 2022
The Endocrine Society announces its endorsement of the bipartisan insulin bill introduced by Sens. Jeanne Shaheen (D-NH) and Susan Collins (R-ME) that would take steps to reduce out-of-pocket costs of insulin, the escalating price of insulin, and formulary management for people with diabetes.
June 14, 2022
Over the past 20 years, despite the overall increase in the use of insulin pumps, there have been few improvements in the ethnic, racial and socioeconomic inequities in insulin pump use among youth with type 1 diabetes, according to a new study presented Tuesday, June 14 at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
June 14, 2022
Growth hormone improves liver health in patients with nonalcoholic fatty liver disease (NAFLD) by reducing liver fat and inflammation, according to a new study presented Tuesday, June 14 at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.
June 21, 2022
Through describing 2 novel mutations of the parathyroid hormone gene, we aim to extend the molecular basis for familial isolated hypoparathyroidism and further refine the proposed mechanisms by which PTH mutations cause hypoparathyroidism.
June 21, 2022
A comprehensive, integrated, and current bench-to-bedside understanding of our field’s investigations into adrenocortical physiology and neoplasia is crucial to developing novel clinical tools and approaches to equip the one-in-a-million patient fighting this devastating disease.
June 21, 2022
To date, prenatal treatments for fetal growth restriction (FGR) have not attempted to correct oxygen and glucose supply simultaneously, so we investigated whether a 5-day correction of oxygen and glucose concentrations in placental insufficiency-FGR fetuses would normalize insulin secretion and glucose metabolism.
